Cargando…

Acute Cardiotoxicity With Concurrent Trastuzumab and Hypofractionated Radiation Therapy in Breast Cancer Patients

Purpose: Radiotherapy for patients with non-metastatic human epidermal growth factor receptor 2 (HER2) positive breast cancer is commonly administered concurrently with adjuvant trastuzumab. However, there is limited data on the use of concurrent trastuzumab and hypofractionated radiotherapy (Hypo-R...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sayan, Mutlay, Abou Yehia, Zeinab, Gupta, Apar, Toppmeyer, Deborah, Ohri, Nisha, Haffty, Bruce G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779787/ https://www.ncbi.nlm.nih.gov/pubmed/31632906 http://dx.doi.org/10.3389/fonc.2019.00970

Ejemplares similares

Hypofractionated Postmastectomy Radiation Therapy
por: Sayan, Mutlay, et al.
Publicado: (2020)

The Impact of Formal Mentorship Programs on Mentorship Experience Among Radiation Oncology Residents From the Northeast
por: Sayan, Mutlay, et al.
Publicado: (2019)

Reconstructive complications and early toxicity in breast cancer patients treated with proton-based postmastectomy radiation therapy
por: Sayan, Mutlay, et al.
Publicado: (2023)

Patterns of postmastectomy radiation therapy in clinically node-positive breast cancer patients with pathologically negative lymph nodes after neoadjuvant chemotherapy
por: SAYAN, Mutlay, et al.
Publicado: (2021)

Incidence of clinical lymphedema in breast cancer patients treated with adjuvant proton-based radiotherapy
por: Sayan, Mutlay, et al.
Publicado: (2022)

Serum Biomarkers for the Detection of Cardiac Toxicity after Chemotherapy and Radiation Therapy in Breast Cancer Patients
por: Tian, Sibo, et al.
Publicado: (2014)

Adjuvant radiation therapy alone is associated with improved overall survival compared to hormonal therapy alone in older women with estrogen receptor positive early stage breast cancer
por: Jhawar, Sachin R., et al.
Publicado: (2020)

Hypofractionated Radiation Therapy for Large Brain Metastases
por: Masucci, Giuseppina Laura
Publicado: (2018)

Breast cancer awareness among Afghan refugee women in Turkey
por: Kizilkaya, Mehmet Celal, et al.
Publicado: (2022)

Accelerated Hypofractionated Radiotherapy in the Era of Concurrent Temozolomide Chemotherapy in Elderly Patients with Glioblastoma Multiforme
por: Greer, Liana, et al.
Publicado: (2017)

Patient-Reported Tolerance of Magnetic Resonance-Guided Radiation Therapy
por: Sayan, Mutlay, et al.
Publicado: (2020)

Trastuzumab Cardiotoxicity in Patients with Breast Cancer
por: Freitas, Aguinaldo Figueiredo, et al.
Publicado: (2014)

Durable Local Control Following Concurrent Hypofractionated Chemoradiation for a Massive Inflammatory Breast Cancer Chest Wall Recurrence
por: Dyer, Brandon A, et al.
Publicado: (2017)

Mild Hypofractionated Radiation Therapy for Merkel Cell Carcinoma
por: Matsui, Toshiaki, et al.
Publicado: (2020)

The Efficacy and Safety of Hypofractionated Radiation Therapy With Tomotherapy for Advanced or Recurrent Hepatocellular Carcinoma
por: Shen, Jie, et al.
Publicado: (2021)

An Initial Evaluation of Human Plasma cMLC-1: A Potential Protein Biomarker for Trastuzumab-Induced Cardiotoxicity, Breast Cancer Screening and Progression
por: Yu, Ling, et al.
Publicado: (2022)

Radiation-Induced Heart Disease: Pathologic Abnormalities and Putative Mechanisms
por: Taunk, Neil K., et al.
Publicado: (2015)

Regression of a Fungating Tumor After Hypofractionated Radiation Therapy in a Patient With Metastatic Breast Cancer
por: Quackenbush, Kevin, et al.
Publicado: (2017)

Effectiveness of a telehealth patient education intervention for breast cancer awareness and screening uptake among Afghan refugee women: a cross-sectional survey and feasibility study
por: Kizilkaya, Mehmet Celal, et al.
Publicado: (2023)

The Role of Hypofractionated Radiation Therapy with Photons, Protons, and Heavy Ions for Treating Extracranial Lesions
por: Laine, Aaron Michael, et al.
Publicado: (2016)

Survival Outcomes of Patients Treated with Hypofractionated Stereotactic Body Radiation Therapy for Parotid Gland Tumors: a Retrospective Analysis
por: Karam, Sana D., et al.
Publicado: (2012)

Hypofractionated concurrent chemoradiotherapy related lymphopenia and its association with survival in locally advanced non-small cell lung cancer patients
por: Liu, FangJie, et al.
Publicado: (2022)

Utilization of radiation therapy and predictors of noncompliance among Syrian refugees in Turkey
por: Sayan, Mutlay, et al.
Publicado: (2022)

Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer
por: Marinko, Tanja, et al.
Publicado: (2014)

Lung-heart toxicity in a randomized clinical trial of hypofractionated image guided radiation therapy for breast cancer
por: Van Parijs, Hilde, et al.
Publicado: (2023)

Optimization of Heart Block in the Left-Sided Whole Breast Radiation Treatments
por: Yue, Ning J., et al.
Publicado: (2014)

Low Incidence of Fatigue after Hypofractionated Stereotactic Body Radiation Therapy for Localized Prostate Cancer
por: Dash, Chiranjeev, et al.
Publicado: (2012)

Hypofractionated electron-beam radiation therapy for keloids: retrospective study of 568 cases with 834 lesions
por: Shen, Jie, et al.
Publicado: (2015)

Management of symptomatic radiation necrosis after stereotactic radiosurgery and clinical factors for treatment response
por: Sayan, Mutlay, et al.
Publicado: (2020)

Treatment Techniques to Reduce Cardiac Irradiation for Breast Cancer Patients Treated with Breast-Conserving Surgery and Radiation Therapy: A Review
por: Beck, Robert E., et al.
Publicado: (2014)

Study protocol: a multicentre, prospective, phase II trial of isotoxic hypofractionated concurrent chemoradiotherapy for non-small cell lung cancer
por: Liu, Yue-E, et al.
Publicado: (2020)

Significance of low-dose radiation distribution in development of radiation pneumonitis after helical-tomotherapy-based hypofractionated radiotherapy for pulmonary metastases
por: Jo, In-Young, et al.
Publicado: (2014)

Cardiovascular Toxicities of Breast Cancer Treatment: Emerging Issues in Cardio-Oncology
por: Goyal, Sharad, et al.
Publicado: (2015)

Cowpea Mosaic Virus Nanoparticle Enhancement of Hypofractionated Radiation in a B16 Murine Melanoma Model
por: Duval, Kayla E. A., et al.
Publicado: (2020)

A novel schedule of accelerated partial breast radiation using intensity-modulated radiation therapy in elderly patients: survival and toxicity analysis of a prospective clinical trial
por: Sayan, Mutlay, et al.
Publicado: (2017)

Hypofractionated Radiotherapy in African Cancer Centers
por: Swanson, William, et al.
Publicado: (2021)

Clinical and Pharmacologic Differences of CDK4/6 Inhibitors in Breast Cancer
por: George, Mridula A., et al.
Publicado: (2021)

Detection of Subclinical Trastuzumab-Induced Cardiotoxicity in Patients with Breast Cancer
por: dos Santos, Marília Harumi Higuchi
Publicado: (2013)

Risks of trastuzumab‐related cardiotoxicity in breast cancer patients in Taiwan
por: Chang, Wei‐Ting, et al.
Publicado: (2021)

Antioxidant Protection against Trastuzumab Cardiotoxicity in Breast Cancer Therapy
por: Méndez-Valdés, Gabriel, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v4ki0jajbn5420tb9hhjmmu7ab